☰

Xin Ming, Ph.D. - Publications

Affiliations: 
2008 Pharmaceutical Sciences University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Pharmacy
Tree Info Similar researchers PubMed Report error

41 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Mao C, Li F, Zhao Y, Debinski W, Ming X. P-glycoprotein-targeted photodynamic therapy boosts cancer nanomedicine by priming tumor microenvironment. Theranostics. 8: 6274-6290. PMID 30613297 DOI: 10.7150/Thno.29580  0.34
2018 Mao C, Qu P, Miley MJ, Zhao Y, Li Z, Ming X. P-glycoprotein targeted photodynamic therapy of chemoresistant tumors using recombinant Fab fragment conjugates. Biomaterials Science. PMID 30298866 DOI: 10.1039/C8Bm00844B  0.302
2018 Suo X, Eldridge BN, Zhang H, Mao C, Min Y, Sun Y, Singh R, Ming X. P-glycoprotein Targeted Photothermal Therapy of Drug Resistant Cancer Cells Using Antibody-conjugated Carbon Nanotubes. Acs Applied Materials & Interfaces. PMID 30188117 DOI: 10.1021/Acsami.8B11974  0.338
2018 Mao C, Zhao Y, Li F, Li Z, Tian S, Debinski W, Ming X. P-glycoprotein targeted and near-infrared light-guided depletion of chemoresistant tumors. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30081143 DOI: 10.1016/J.Jconrel.2018.08.005  0.336
2018 Zhao Y, Li F, Mao C, Ming X. Multi-arm Nanoconjugates for Cancer Cell-Targeted Delivery of Photosensitizers. Molecular Pharmaceutics. PMID 29764120 DOI: 10.1021/Acs.Molpharmaceut.8B00088  0.353
2018 Juliano RL, Wang L, Tavares F, Brown EG, James L, Ariyarathna Y, Ming X, Mao C, Suto M. Structure-activity relationships and cellular mechanism of action of small molecules that enhance the delivery of oligonucleotides. Nucleic Acids Research. PMID 29361039 DOI: 10.1093/Nar/Gkx1320  0.359
2017 Wang L, Ariyarathna Y, Ming X, Yang B, James LI, Kreda SM, Porter M, Janzen W, Juliano RL. A Novel Family of Small Molecules that Enhance the Intracellular Delivery and Pharmacological Effectiveness of Antisense and Splice Switching Oligonucleotides. Acs Chemical Biology. PMID 28703575 DOI: 10.1021/Acschembio.7B00242  0.342
2017 Li F, Zhao Y, Mao C, Kong Y, Ming X. RGD-Modified Albumin Nanoconjugates for Targeted Delivery of a Porphyrin Photosensitizer. Molecular Pharmaceutics. PMID 28700237 DOI: 10.1021/Acs.Molpharmaceut.7B00321  0.361
2016 Yang B, Ming X, Abdelkafi H, Pons V, Michau A, Gillet D, Cintrat JC, Barbier J, Juliano R. Retro-1 Analogues Differentially Affect Oligonucleotide Delivery and Toxin Trafficking. Chemmedchem. PMID 27778487 DOI: 10.1002/Cmdc.201600463  0.361
2016 Proctor WR, Ming X, Bourdet D, Han TK, Everett RS, Thakker DR. Why Does the Intestine Lack Basolateral Efflux Transporters for Cationic Compounds? A Provocative Hypothesis. Journal of Pharmaceutical Sciences. 105: 484-96. PMID 26869413 DOI: 10.1016/J.Xphs.2015.11.040  0.7
2015 Yuan A, Hu Y, Ming X. Dendrimer Conjugates for Light-activated Delivery of Antisense Oligonucleotides. Rsc Advances. 5: 35195-35200. PMID 26146545 DOI: 10.1039/C5Ra04091D  0.347
2015 Ming X, Wu L, Carver K, Yuan A, Min Y. Dendritic nanoconjugates for intracellular delivery of neutral oligonucleotides. Nanoscale. 7: 12302-6. PMID 26134311 DOI: 10.1039/C5Nr01665G  0.348
2015 Yuan A, Yang B, Wu J, Hu Y, Ming X. Dendritic nanoconjugates of photosensitizer for targeted photodynamic therapy. Acta Biomaterialia. 21: 63-73. PMID 25900441 DOI: 10.1016/J.Actbio.2015.04.014  0.358
2015 Yuan A, Laing B, Hu Y, Ming X. Direct oligonucleotide-photosensitizer conjugates for photochemical delivery of antisense oligonucleotides. Chemical Communications (Cambridge, England). 51: 6678-80. PMID 25786195 DOI: 10.1039/C5Cc00573F  0.357
2015 Ming X, Laing B. Bioconjugates for targeted delivery of therapeutic oligonucleotides. Advanced Drug Delivery Reviews. 87: 81-9. PMID 25689735 DOI: 10.1016/J.Addr.2015.02.002  0.368
2015 Yang B, Ming X, Cao C, Laing B, Yuan A, Porter MA, Hull-Ryde EA, Maddry J, Suto M, Janzen WP, Juliano RL. High-throughput screening identifies small molecules that enhance the pharmacological effects of oligonucleotides. Nucleic Acids Research. 43: 1987-96. PMID 25662226 DOI: 10.1093/Nar/Gkv060  0.342
2014 Carver K, Ming X, Juliano RL. Tumor cell-targeted delivery of nanoconjugated oligonucleotides in composite spheroids. Nucleic Acid Therapeutics. 24: 413-9. PMID 25238564 DOI: 10.1089/Nat.2014.0493  0.319
2014 Carver K, Ming X, Juliano RL. Multicellular tumor spheroids as a model for assessing delivery of oligonucleotides in three dimensions. Molecular Therapy. Nucleic Acids. 3: e153. PMID 24618852 DOI: 10.1038/Mtna.2014.5  0.342
2014 Juliano RL, Ming X, Carver K, Laing B. Cellular uptake and intracellular trafficking of oligonucleotides: implications for oligonucleotide pharmacology. Nucleic Acid Therapeutics. 24: 101-13. PMID 24383421 DOI: 10.1089/Nat.2013.0463  0.375
2014 Nakagawa O, Ming X, Carver K, Juliano R. Conjugation with receptor-targeted histidine-rich peptides enhances the pharmacological effectiveness of antisense oligonucleotides. Bioconjugate Chemistry. 25: 165-70. PMID 24354269 DOI: 10.1021/Bc400500H  0.347
2013 Ming X, Carver K, Wu L. Albumin-based nanoconjugates for targeted delivery of therapeutic oligonucleotides. Biomaterials. 34: 7939-49. PMID 23876758 DOI: 10.1016/J.Biomaterials.2013.06.066  0.33
2013 Alam MR, Ming X, Nakagawa O, Jin J, Juliano RL. Covalent conjugation of oligonucleotides with cell-targeting ligands. Bioorganic & Medicinal Chemistry. 21: 6217-23. PMID 23777829 DOI: 10.1016/J.Bmc.2013.05.037  0.341
2013 Ming X, Carver K, Michael Fisher, Romain Noel, Cintrat JC, Gillet D, Barbier J, Cao C, Bauman J, Juliano RL. The small molecule Retro-1 enhances the pharmacological actions of antisense and splice switching oligonucleotides Nucleic Acids Research. 41: 3673-3687. PMID 23396438 DOI: 10.1093/Nar/Gkt066  0.332
2012 Juliano RL, Carver K, Cao C, Ming X. Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides. Journal of Drug Targeting. 21: 27-43. PMID 23163768 DOI: 10.3109/1061186X.2012.740674  0.318
2012 Kotula JW, Pratico ED, Ming X, Nakagawa O, Juliano RL, Sullenger BA. Aptamer-mediated delivery of splice-switching oligonucleotides to the nuclei of cancer cells. Nucleic Acid Therapeutics. 22: 187-95. PMID 22703281 DOI: 10.1089/Nat.2012.0347  0.327
2012 Ming X, Feng L. Targeted delivery of a splice-switching oligonucleotide by cationic polyplexes of RGD-oligonucleotide conjugate. Molecular Pharmaceutics. 9: 1502-10. PMID 22497548 DOI: 10.1021/Mp300113C  0.356
2012 Juliano RL, Ming X, Nakagawa O. The chemistry and biology of oligonucleotide conjugates. Accounts of Chemical Research. 45: 1067-76. PMID 22353142 DOI: 10.1021/Ar2002123  0.382
2012 Juliano RL, Ming X, Nakagawa O. Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotides. Bioconjugate Chemistry. 23: 147-57. PMID 21992697 DOI: 10.1021/Bc200377D  0.383
2011 Ming X, Knight BM, Thakker DR. Vectorial transport of fexofenadine across Caco-2 cells: involvement of apical uptake and basolateral efflux transporters. Molecular Pharmaceutics. 8: 1677-86. PMID 21780830 DOI: 10.1021/Mp200026V  0.712
2011 Alam MR, Ming X, Fisher M, Lackey JG, Rajeev KG, Manoharan M, Juliano RL. Multivalent cyclic RGD conjugates for targeted delivery of small interfering RNA. Bioconjugate Chemistry. 22: 1673-81. PMID 21755983 DOI: 10.1021/Bc200235Q  0.389
2011 Ming X, Sato K, Juliano RL. Unconventional internalization mechanisms underlying functional delivery of antisense oligonucleotides via cationic lipoplexes and polyplexes. Journal of Controlled Release : Official Journal of the Controlled Release Society. 153: 83-92. PMID 21571016 DOI: 10.1016/J.Jconrel.2011.04.029  0.393
2011 Juliano RL, Ming X, Nakagawa O, Xu R, Yoo H. Integrin targeted delivery of gene therapeutics. Theranostics. 1: 211-9. PMID 21547161 DOI: 10.7150/Thno/V01P0211  0.368
2011 Ming X. Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis. Expert Opinion On Drug Delivery. 8: 435-49. PMID 21381985 DOI: 10.1517/17425247.2011.561313  0.366
2010 Ming X, Alam MR, Fisher M, Yan Y, Chen X, Juliano RL. Intracellular delivery of an antisense oligonucleotide via endocytosis of a G protein-coupled receptor. Nucleic Acids Research. 38: 6567-76. PMID 20551131 DOI: 10.1093/Nar/Gkq534  0.376
2010 Nakagawa O, Ming X, Huang L, Juliano RL. Targeted intracellular delivery of antisense oligonucleotides via conjugation with small-molecule ligands. Journal of the American Chemical Society. 132: 8848-9. PMID 20550198 DOI: 10.1021/Ja102635C  0.334
2010 Alam MR, Ming X, Dixit V, Fisher M, Chen X, Juliano RL. The biological effect of an antisense oligonucleotide depends on its route of endocytosis and trafficking. Oligonucleotides. 20: 103-9. PMID 20038250 DOI: 10.1089/Oli.2009.0211  0.348
2010 Ming X, Thakker DR. Role of basolateral efflux transporter MRP4 in the intestinal absorption of the antiviral drug adefovir dipivoxil. Biochemical Pharmacology. 79: 455-62. PMID 19735648 DOI: 10.1016/J.Bcp.2009.08.029  0.624
2010 Proctor WR, Ming X, Thakker DR. In vitro techniques to study drug-drug interactions involving transport: Caco-2 model for study of P-glycoprotein and other transporters Enzyme- and Transporter-Based Drug-Drug Interactions: Progress and Future Challenges. 257-282. DOI: 10.1007/978-1-4419-0840-7_10  0.578
2009 Juliano R, Bauman J, Kang H, Ming X. Biological barriers to therapy with antisense and siRNA oligonucleotides. Molecular Pharmaceutics. 6: 686-95. PMID 19397332 DOI: 10.1021/Mp900093R  0.36
2009 Ming X, Ju W, Wu H, Tidwell RR, Hall JE, Thakker DR. Transport of dicationic drugs pentamidine and furamidine by human organic cation transporters. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 37: 424-30. PMID 18971316 DOI: 10.1124/Dmd.108.024083  0.62
2003 Cheng X, Ming X, Croyle MA. PEGylated adenoviruses for gene delivery to the intestinal epithelium by the oral route. Pharmaceutical Research. 20: 1444-51. PMID 14567640 DOI: 10.1023/A:1025714412337  0.317
Show low-probability matches.